Techniques in Regional Anesthesia & Pain Management
Volume 10, Issue 2 , Pages 46-55 , April 2006

Managing anticoagulant and antiplatelet drugs in patients who are receiving neuraxial anesthesia and epidural analgesia: a practical guide for clinicians

  • James D. Douketis, MD, FRCP(C)

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. James D. Douketis, St. Joseph’s Hospital, Room F-544, 50 Charlton Ave. East, Hamilton, ON, Canada, L8N 4A6
    • ,
  • Francesco Dentali, MD

References 

  1. Lawton MT , Porter RW , Heiserman JE , et al.  Surgical management of spinal epidural hematoma (relationship between surgical timing and neurological outcome) . J Neurosurg . 1995;83:1–7
  2. Hirsh J , Raschke R . Heparin and low-molecular-weight heparin (the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy) . Chest . 2004;126(suppl):188S–203S
  3. Basu D , Gallus A , Hirsh J , et al.  A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time . N Engl J Med . 1972;287:324–327
  4. Fareed J , Jeske W , Hoppensteadt D , et al.  Low-molecular-weight heparins (pharmacological profile and product differentiation) . Am J Cardiol . 1998;82:3L–10L
  5. Hirsh J , Levine MN . Low molecular weight heparin . Blood . 1992;79:1–17
  6. Warkentin TE , Levine MN , Hirsh J , et al.  Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin . N Engl J Med . 1995;332:1330–1335
  7. Turpie AG , Gallus AS , Hoek JA . Pentasaccharide Investigators. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement . N Engl J Med . 2001;344:619–625
  8. Ansell J , Hirsh J , Poller L , et al.  The pharmacology and management of the vitamin K antagonists (the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy) . Chest . 2004;126(suppl):204S–233S [Published erratum in Chest 127:415-416, 2005]
  9. Shields RC , McBane RD , Kuiper JD , et al.  Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy . Mayo Clin Proc . 2001;76:260–266
  10. Patrono C , Coller B , FitzGerald GA , et al.  Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest . 2004;126(suppl):234S–264S
  11. Coukell AJ . Clopidogrel . Drugs . 1997;54:745–750
  12. Crowther MA , Berry LR , Monagle PT , et al.  Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin . Br J Haematol . 2002;116:178–186
  13. Warkentin TE , Crowther MA . Reversing anticoagulants both old and new . Can J Anaesth . 2002;49:S11–S25
  14. Landow L . A synthetic pentasaccharide for the prevention of deep-vein thrombosis . [Letter] N Engl J Med . 2001;345:291–292
  15. Turpie AG , Gallus AS , Hoek JA . Pentasaccharide Investigators. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement . N Engl J Med . 2001;345:292; [Letter]
  16. Odoom JA , Sih IL . Epidural analgesia and anticoagulant therapy (experience with one thousand cases of continuous epidurals) . Anaesthesia . 1983;38:254–259
  17. Horlocker TT , Wedel DJ , Schlicting JL . Postoperative epidural analgesia and oral anticoagulant therapy . Anesth Analg . 1994;79:89–93
  18. Wu CL , Perkins FM . Oral anticoagulant prophylaxis and epidural catheter removal . Reg Anesth Pain Med . 1996;21:517–524
  19. Woolson ST , Robinson RK , Khan NQ , et al.  Deep venous thrombosis prophylaxis for knee replacement (warfarin and pneumatic compression) . Am J Orthop . 1998;27:299–304
  20. Badenhorst CH . Epidural hematoma after epidural pain control and concomitant postoperative anticoagulation . Reg Anesth Pain Med . 1996;21:272–273
  21. CLASP (Collaborative Low-Dose Aspirin Study in Pregnancy) Collaborative Group . CLASP (a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women) . Lancet . 1994;343:619–629
  22. Dyke CM . Safety of glycoprotein IIb-IIIa inhibitors (a heart surgeon’s perspective) . Am Heart J . 1999;138:307–316 [Review]
  23. Rodgers A , Walker N , Schug S , et al.  Reduction of postoperative mortality and morbidity with epidural or spinal anesthesia (results from overview of randomised trials) . Br Med J . 2000;321:1493
  24. Rigg JR , Jamrozik K , Myles PS , et al.  Epidural anesthesia and analgesia and outcome after major surgery (a randomised trial) . Lancet . 2002;359:1276–1282
  25. Choi P , Bhandari M , Scott J , et al.  Epidural analgesia for pain relief following hip or knee replacement . Cochrane Database Syst Rev . 2003;3:CD003071
  26. Geerts WH , Pineo GF , Heit JA , et al.  Prevention of venous thromboembolism. Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest . 2004;126:338S–400S
  27. Hull RD , Pineo GF , Stein PD , et al.  Timing of initial administration of low-molecular weight heparin prophylaxis against deep vein thrombosis in patients following hip arthroplasty . Arch Intern Med . 2001;161:1952–1960
  28. Kakkar VV , Flanc C , Howe CT , et al.  Natural history of postoperative deep-vein thrombosis . Lancet . 1969;1:230–232
  29. Horlocker TT , Heit JA . Low molecular weight heparin (biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines or regional anesthetic management) . Anesth Analg . 1997;85:874–885
  30. Lumpkin MM . FDA Public Health Advisory (Reports of epidural or spinal hematomas with the concurrent use of low molecular weight heparin and spinal/epidural anesthesia or spinal puncture) . Anesthesiology . 1999;88:27A–28A
  31. Schroeder DR . Statistics (detecting a rare adverse drug reaction using spontaneous reports) . Reg Anesth Pain Med . 1998;23(suppl 2):183–189
  32. Horlocker TT . Low molecular weight heparin and neuraxial anesthesia . Thromb Res . 2001;101:V141–V154
  33. Tryba M , Wedel DJ . Central neuraxial block and low molecular weight heparin (enoxaparin). Lessons learned from two different dosage regimens in two continents . Acta Anaesthesiol Scand . 1997;41(suppl 111):100–104
  34. Canavaro D . Periopertive use of low-molecular-weight heparin (letter) . J Bone Joint Surg . 2000;82-A:1673–1674
  35. Douketis JD , Kinnon K , Crowther MA . Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgery . Thromb Haemost . 2002;88:37–40
  36. Hirsh J , Warkentin TE , Shaughnessy  , et al.  Heparin and low-molecular-weight heparin (mechanism of action, pharmacokinetics, dosing, monitoring, efficacy, safety) . Chest . 2001;119:64S–94S
  37. Horlocker TT , Wedel DJ , Benzon H , et al.  Regional anesthesia in the anticoagulated patient. Defining the risks . Reg Anesth Pain Med . 2004;29(suppl):1–12
  38. Schwander D , Bachmann F . Herparine et anesthesies medullaires (analyse de decision) . Ann Fr Anesth Reanim . 1991;10:284–296
  39. Wang J , Douketis JD . Safety of co-administered epidural analgesia and low-molecular-weight heparin after orthopedic surgery . Blood . 2004;104:198a
  40. Boneau B , Necciari J , Cariou R , et al.  Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org 31540) with high affinity to antithrombin III in man . Thromb Haemost . 1995;74: 1486–1473
  41. Turpie AG , Bauer KA , Eriksson BI , et al.  Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery (a meta-analysis of 4 randomized double-blind studies) . Arch Intern Med . 2002;162:1833–1840

PII: S1084-208X(06)00022-X

doi: 10.1053/j.trap.2006.04.004

Techniques in Regional Anesthesia & Pain Management
Volume 10, Issue 2 , Pages 46-55 , April 2006

Article Tools

* Image Usage & Resolution